Biostatistician Offshore

A biostatistician offshore plans and runs the stats for a trial from a hub in another country. Think sample size, the analysis plan, the code that builds the tables, and the final read-out. It’s set up to be checked by anyone who asks.

The craft is statistical programming, usually in SAS or R. A sponsor writes the question; the statistician turns it into a testable design, a pre-specified plan, and code that returns the same answer every time it runs.

Distance matters less here than in most roles. The inputs are data and a protocol, the outputs are files, and every step leaves an audit trail. That’s why so much of this work now sits in Manila, Bengaluru, Kraków and Kuala Lumpur.

Key takeaways

• Offshore biostatisticians own sample size, the statistical analysis plan (SAP), randomisation, and the tables, listings and figures a submission needs.
• Statistical programming in SAS or R is the daily craft, and it gets reviewed line by line rather than taken on trust.
• Pay anchors the business case: U.S. statisticians earned a median $103,300 in May 2024, against $49,500 across all occupations.
• Demand is rising — employment of mathematicians and statisticians is projected to grow 8 percent from 2024 to 2034.

How it works

An offshore biostatistics team works to the protocol, not to the clock. You hand over the study design and the data; they return a sample size, a statistical analysis plan, validated code, and the output tables that regulators and journals expect.

The sequence rarely changes. Power calculation first, then the SAP, then randomisation, then double programming, then the final analysis once the database is locked.

Pay is the reason many sponsors look abroad in the first place. The U.S. Bureau of Labor Statistics put the median wage for statisticians at $103,300 in May 2024, with the top 10% above $170,700.

Entry is not cheap on the supply side either. Most statistician roles need a master’s degree in mathematics or statistics, though some are open to bachelor’s holders, and the lowest-paid 10% still earned $60,390 in May 2024.

Quality control sits inside the process rather than after it. Independent double programming, version-controlled code and a documented quality assurance trail let a reviewer in Boston rerun a Manila analysis and land on the same number.

That reproducibility is the whole argument. If two people in two countries can produce identical output from the same raw data, the location of the second person stops being an interesting question.

Endpoints are not negotiable once a study is registered. A trial’s pre-specified endpoints become a public commitment on ClinicalTrials.gov, the federal registry and results database run by the National Library of Medicine.

For a U.S. drug programme, the analysis reports into 21 CFR Part 312, the Investigational New Drug Application (IND) regulation. That framework — not the seating plan — sets the standard the work has to meet.

Time zones are handled by design, not by heroics. Most teams run a written handover, a shared issue log and a weekly statistical review, so questions queue in one place instead of scattering across inboxes.

Nothing here depends on being in the room. The protocol, the SAP and the code review are all written artefacts, and written artefacts cross borders without losing anything.

Examples

Offshore biostatistics shows up across the health economy, not just in pharma. Contract research organisations, device makers, public health agencies and payer teams all buy the same core skill: a defensible number, produced on time and open to audit.

Clinical research services in India and the Philippines. Sponsors route statistical programming to offshore delivery centres while medical writing and regulatory strategy stay onshore. The offshore team builds the tables; the sponsor signs them.

Medical device studies. Post-market surveillance produces a steady flow of adverse event (AE) reports and registry data. Offshore statisticians run the recurring safety analyses that keep a device file current between submissions.

Registry and observational research. Long-running cohort studies need the same analyses repeated every quarter. That rhythm suits an offshore team, which can hold the code, the specifications and the institutional memory in one place.

Public health and payer analytics. Teams working on population health build risk models from claims and electronic health record (EHR) extracts. The statistical methods are the same; only the data source changes.

Academic and non-profit trials. Budgets are tighter here, so one offshore statistician often covers several studies at once, splitting time across protocols in different phases.

Against a U.S. median of $103,300 in May 2024, a shared offshore resource is sometimes the only way a small investigator-led trial gets a qualified statistician at all.

Supply pressure is the other half of the story. The BLS projects about 2,200 openings a year for mathematicians and statisticians across the 2024–2034 decade, with 8 percent growth — much faster than the average for all occupations.

Read that alongside the $49,500 median for all U.S. occupations in May 2024 and the picture is plain. Statistical talent is scarce, expensive, and increasingly sourced wherever the qualified people happen to live.

Related terms

Biostatistics offshore sits next to a family of analytics and sourcing terms. Knowing which one you actually need saves real scoping time, because a trial statistician and a reporting analyst solve very different problems with similar-looking tools.

• Data Analyst: a generalist who queries and reports on data without owning study design or inference.
• Healthcare Data Analyst: a clinical-data specialist focused on operations and outcomes rather than trial inference.
• Business Intelligence Analyst: a reporting and dashboard role serving commercial decisions, not regulatory filings.
• Data Quality Analyst: a gatekeeper for completeness and consistency before any analysis begins.
• Knowledge Process Outsourcing (KPO): the wider category of judgement-heavy offshore work that biostatistics belongs to.
• Offshore Outsourcing: the delivery model that places the statistical team in a different country from the sponsor.

FAQ

What does an offshore biostatistician actually do?

They design and run the statistical side of a study: sample size, the SAP, randomisation, and the analysis behind the final tables. Most of the day is spent writing and checking code in SAS or R. The location changes nothing about the method.

Is SAS or R better for offshore clinical work?

SAS still dominates regulatory submissions, because sponsors and reviewers expect its output formats and audit behaviour. R is gaining ground in exploratory work and academic trials. Most offshore teams keep both and hire people who can move between them.

Do you need a master’s degree to be a biostatistician?

Usually, yes. The BLS notes that most statistician roles require a master’s degree in mathematics or statistics, though some are open to bachelor’s holders. Offshore hiring follows the same pattern, often with a clinical-research certificate on top.

Can an offshore team work on U.S. drug submissions?

Yes, and plenty already do. What matters is the audit trail, not the postcode: the analysis reports into 21 CFR Part 312, outputs are double-programmed, and the endpoints are already public. Sponsors keep final sign-off onshore.

How much cheaper is an offshore biostatistician?

Rates vary by market and seniority, but the saving comes from a lower salary base than the $103,300 U.S. median recorded in May 2024 — not from cutting review steps.

If you’re mapping where statistical programming capacity actually sits, the Outsource Accelerator hubs pages are a practical place to compare delivery locations side by side.